Zürich-based ZuriMED Technologies, a biotechnology company, announced that it has raised €15m in a Series A round of funding. The round was led by Chindex Medical Limited and was joined by Yellowstone Holding AG and a group of private investors, including prominent orthopedic surgeons from Switzerland, France, Germany, and the U.S. ZuriMED says that it plans to use … Continue reading Zürich-based ZuriMED secures €15M